According to new market report "EpiCast Report: Gram-Negative Bacterial Pneumonia - Epidemiology Forecast to 2022" at marketinforesearch.com, Pneumonia is one of the most common infectious diseases and a major public health concern in both developed and developing countries (Farr et al., 2000). This report provides an overview of the risk factors and epidemiological trends for pneumonia, with a focus on gram-negative bacteria, in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast of incident cases of community-acquired pneumonia (CAP) segmented by sex and age (in five-year increments beginning at 0 years and ending at ≥85 years), incident cases of hospital-acquired pneumonia (HAP), and incident cases of ventilator-associated pneumonia (VAP). HAP cases are further segmented by causative pathogens (Acinetobacter, Escherichia coli, Klebsiella, and Pseudomonas) and antibiotic resistance in these markets.
Pneumonia is an acute respiratory infection that inflames the alveoli (air sacs) in the lungs through fluid or pus (WHO, 2013). Chronic diseases such as asthma, chronic obstructive pulmonary disease, and heart disease increase the risk of developing pneumonia. Elderly patients (65 years and older) have twice the incidence of hospital-acquired pneumonia compared with the adult population. Additionally, tobacco smoking has been identified as a cause of pneumonia.
The forecast incident cases of CAP in the 6MM (US, France, Germany, Italy, Spain, UK) for 2012 and 2022. In 2012, the 6MM had 4,184,449 incident cases of CAP, with 82% of that occurring in the US. By 2022, GlobalData epidemiologists forecast there will be 4,670,664 incident cases of CAP in the 6MM.
In Japan (not shown), there were 40,043 cases of CAP and HAP with an annual growth rate (AGR) of 3.78%. By 2022, GlobalData epidemiologists forecast there will be 55,188 cases of CAP and HAP in Japan.
These 7MM are important markets for CAP and HAP during the next 10 years because these countries have a growing older population. Pneumonia incidence differs between countries, possibly due to socioeconomic factors, differences in infectious disease reporting, and heterogeneity of diagnostics.
From a public health perspective, effective prevention and treatment measures should be in place to avoid disease transmission and reduce the incidence of pneumonia.
No comments:
Post a Comment